Table 1.
Demographical characteristics of patients initiating HCV treatment by year of initiation and type of therapy, France, 2007–2015
| Year | PEG-IFN/RBV bitherapy | 1st- wave protease inhibitors | 2nd- wave direct-acting antivirals | Totalb | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n | % men | Mean age (SD) | n | % men | Mean age (SD) | n | % men | Mean age (SD) | n | % men | Mean age (SD) | |||||
| Men | Women | Men | Women | Men | Women | Men | Women | |||||||||
| 2007 | 12,255 | 64.0 | 47.0 (10.4) | 52.4 (12.8) | 0 | – | – | – | 0 | – | – | – | 12,255 | 64.0 | 47.0 (10.4) | 52.4 (12.8) |
| 2008 | 11,317 | 65.3 | 47.1 (10.0) | 52.1 (12.4) | 0 | – | – | – | 0 | – | – | – | 11,317 | 65.3 | 47.1 (10.0) | 52.1 (12.4) |
| 2009 | 11,332 | 66.2 | 47.6 (9.9) | 52.8 (12.1) | 0 | – | – | – | 0 | – | – | – | 11,332 | 66.2 | 47.6 (9.9) | 52.8 (12.1) |
| 2010 | 9935 | 66.7 | 47.8 (10.2) | 52.6 (12.0) | 0 | – | – | – | 0 | – | – | – | 9935 | 66.7 | 47.8 (10.2) | 52.6 (12.0) |
| 2011 | 9565 | 67.1 | 48.2 (10.4) | 54.1 (12.0) | 1265 | 68.1 | 52.8 (9.0) | 56.5 (10.3) | 0 | – | – | – | 10,325 | 67.2 | 48.6 (10.4) | 54.3 (11.9) |
| 2012 | 7821 | 68.8 | 48.7 (10.7) | 54.3 (12.5) | 6037 | 65.4 | 51.9 (9.3) | 57.3 (11.0) | 0 | – | – | – | 12,488 | 67.4 | 49.9 (10.4) | 55.6 (12.0) |
| 2013 | 5640 | 71.8 | 47.7 (11.0) | 54.5 (12.3) | 3199 | 67.7 | 51.5 (9.6) | 56.0 (11.6) | 40 | c | c | c | 8382 | 70.5 | 48.9 (10.7) | 55.2 (12.0) |
| 2014 | 2969 | 74.8 | 47.9 (11.3) | 55.0 (12.3) | 474 | 70.9 | 50.1 (9.7) | 53.4 (12.3) | 8702 | 65.9 | 55.3 (9.2) | 62.3 (10.9) | 11,630 | 68.0 | 53.1 (10.5) | 60.7 (11.7) |
| 2015 | 536 | 83.4 | 38.7 (11.5) | 49.1 (13.4) | 35 | c | c | c | 14,650 | 64.4 | 54.9 (10.0) | 62.1 (11.9) | 15,189 | 65.1 | 54.2 (10.7) | 61.9 (12.0) |
| Totala | 53,794 | 66.4 | 47.1 (10.5) | 52.7 (12.5) | 10,260 | 66.5 | 51.8 (9.4) | 56.7 (11.2) | 22,565 | 64.8 | 55.1 (9.8) | 62.2 (11.6) | 72,277 | 65.6 | 48.9 (11.0) | 55.0 (13.0) |
PEG-IFN Pegylated Interferon α, RBV Ribavirin, SD standard deviation
aThe total for the 2007–2015 period is less than the sum of the annual numbers of patients because some patients may have initiated successive HCV treatments during the period. The total number of patients initiating a treatment (n = 72,277) during the 2007–2015 period is less than the sum of numbers of patients by type of therapy because some patients may have initiated successive HCV treatments with different types of therapies during the period
bThe annual number of patients initiating a treatment was less than the sum of the annual numbers of patients by type of therapy because some patients may have initiated successive HCV treatments with different types of therapies during the same year
cData not available because of small numbers